Document Detail


Role of endogenous platelet-activating factor in the regulation of pancreatic blood flow during caerulein stimulation.
MedLine Citation:
PMID:  8726834     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The role of endogenous platelet-activating factor (PAF) in the control of pancreatic blood flow during caerulein stimulation was investigated. Pancreatic blood flow in anesthetized rats was measured continuously by laser Doppler flowmetry for 2 h during the intravenous infusion of caerulein (0.25 micrograms/kg per h). Pancreatic blood flow showed a gradual, consistent, and significant increase, reaching 114.2 +/- 2.3% of the basal value after 120 min. Changes in pancreatic blood flow induced by caerulein were completely inhibited by a cholecystokinin (CCK) antagonist (loxiglumide, 5 mg/ kg per h, i.v.) and by a specific PAF antagonist (CV-6209, 1 mg/kg, i.v.-bolus). Systemic blood pressure remained stable in all groups. These results suggest an important role of endogenously yielded PAF in regulating pancreatic blood flow during caerulein stimulation to the pancreas.
Authors:
M Ogura; Y Kubota; K Inoue
Related Documents :
4033194 - Effect of increased systemic venous pressure on thoracic duct and peripheral lymph flow...
1744444 - Mechanisms of acute pancreatitis. vascular etiology.
10795554 - Frequency of pancreatitis after endoscopic retrograde cholangiopancreatography with iop...
15914284 - Redox status of dogs with non-hodgkin lymphomas. an esr study.
1887774 - Abr findings in vertebrobasilar ischemia.
12632034 - Assessment of blood coagulation in severe liver disease using thromboelastography: use ...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of gastroenterology     Volume:  31     ISSN:  0944-1174     ISO Abbreviation:  J. Gastroenterol.     Publication Date:  1996 Jun 
Date Detail:
Created Date:  1996-10-23     Completed Date:  1996-10-23     Revised Date:  2003-11-14    
Medline Journal Info:
Nlm Unique ID:  9430794     Medline TA:  J Gastroenterol     Country:  JAPAN    
Other Details:
Languages:  eng     Pagination:  414-9     Citation Subset:  IM    
Affiliation:
Third Department of Internal Medicine, Kansai Medical University, Osaka, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Caerulein / pharmacology*
Cholecystokinin / antagonists & inhibitors
Gastrointestinal Agents / pharmacology*
Hormone Antagonists / pharmacology
Laser-Doppler Flowmetry
Male
Pancreas / blood supply*
Platelet Activating Factor / antagonists & inhibitors,  physiology*
Proglumide / analogs & derivatives,  pharmacology
Pyridinium Compounds / pharmacology
Rats
Rats, Wistar
Regional Blood Flow / drug effects
Stimulation, Chemical
Time Factors
Chemical
Reg. No./Substance:
0/Gastrointestinal Agents; 0/Hormone Antagonists; 0/Platelet Activating Factor; 0/Pyridinium Compounds; 100488-87-7/CV 6209; 107097-80-3/loxiglumide; 17650-98-5/Caerulein; 6620-60-6/Proglumide; 9011-97-6/Cholecystokinin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Role of endogenous and exogenous cholecystokinin in experimental acute pancreatitis induced in rats ...
Next Document:  Gastric duplication cyst: evaluation by endoscopic ultrasonography and magnetic resonance imaging.